SEC Form D filing

Contraline, Inc.

Biotech · Growth · Regulation D 506(b) · VA · Filed June 10, 2026

Offering amount

$115.9M

Exemption

Reg D 506(b)

Issuer state

Filing date

June 10, 2026

Signature date

June 10, 2026

CIK

0001818752

Summary

Auto-generated

Biotech company developing male contraception, raising a $115.9M growth round in VA.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.